Some people believe Paxlovid does little for COVID, but they leave out vital information. The EPIC-HR study showed Paxlovid’s high effectiveness for high-risk patients, but the EPID-SR study found it no better than placebo for standard-risk patients. It’s crucial to consider both studies before forming an opinion on Paxlovid’s efficacy.
Does Paxlovid Do Little Or Nothing for COVID? Read More »
The FDA did not change its position on Ivermectin’s ineffectiveness against COVID-19, despite settling a lawsuit. The agency reiterated that available data do not demonstrate its efficacy and have not authorized its use for COVID-19. Ivermectin’s misconception as a COVID treatment stems from initial in vitro studies, which subsequent research discredited. This has diverted attention from proven treatments like Paxlovid and Remdesivir.
Does the FDA have to say Ivermectin works for COVID because they lost a lawsuit? Read More »
